Tick-borne Encephalitis
A viral infection of the brain and surrounding tissues transmitted mainly by infected ticks in parts of Europe and Asia.
What causes Tick-borne Encephalitis?
Tick-borne encephalitis virus is a flavivirus transmitted by Ixodes ticks. Rare foodborne infections follow consumption of unpasteurized milk or cheese from infected goats, sheep, or cows.
Symptoms and what to notice
Many infections are asymptomatic. Illness may begin with fever, fatigue, headache, muscle aches, and nausea, followed after a symptom-free interval by meningitis or encephalitis with high fever, stiff neck, confusion, weakness, tremor, or seizures.
How long can it last?
Symptoms usually begin 7 to 14 days after a tick bite. Neurologic illness may last weeks, and recovery from fatigue, weakness, or cognitive effects can take months or remain incomplete.
How serious is Tick-borne Encephalitis?
Encephalitis can cause paralysis, persistent neurologic disability, cognitive problems, or death. Risk of severe disease rises with age and varies by viral subtype.
Treatment and management
No specific antiviral is available. Treatment is supportive and may include hospitalization, seizure control, respiratory support, rehabilitation, and management of brain swelling or other complications.
Vaccine: who and when?
TICOVAC is the only U.S.-licensed TBE vaccine and is approved from age 1 year. It uses a three-dose series: dose spacing differs for ages 1-15 and 16 or older, and a booster may be given at least three years later when exposure risk continues.
Cost note: Patient cost varies by product, provider, insurance, location, and eligibility. Many recommended vaccines are covered in network without cost sharing, and qualifying children may use the Vaccines for Children program.
Trusted source
Patient cost varies by insurance, provider, location, and eligibility. Coverage and public-health access differ, so listed prices are examples rather than guaranteed patient prices. This page is for general education and does not replace individualized medical advice, diagnosis, vaccination assessment, or treatment.
Tick-borne Encephalitis: Symptoms, Causes, Treatment, Prevention, and Vaccine Information
TBE is a travel-associated risk for most U.S. residents. Infection occurs in focal forest and rural areas from western Europe across northern and eastern Asia, primarily during warmer months when ticks are active. Outdoor duration, activities, season, destination, and accommodation determine risk more than country name alone.
Important: This page is for general education. It does not replace diagnosis, treatment, vaccination advice, or emergency care from a qualified healthcare professional.
Quick Facts
| Topic | Current information |
|---|---|
| Cause | Tick-borne encephalitis virus is a flavivirus transmitted by Ixodes ticks. Rare foodborne infections follow consumption of unpasteurized milk or cheese from infected goats, sheep, or cows. |
| Main symptoms | Many infections are asymptomatic. Illness may begin with fever, fatigue, headache, muscle aches, and nausea, followed after a symptom-free interval by meningitis or encephalitis with high fever, stiff neck, confusion, weakness, tremor, or seizures. |
| Typical course | Symptoms usually begin 7 to 14 days after a tick bite. Neurologic illness may last weeks, and recovery from fatigue, weakness, or cognitive effects can take months or remain incomplete. |
| Treatment | No specific antiviral is available. Treatment is supportive and may include hospitalization, seizure control, respiratory support, rehabilitation, and management of brain swelling or other complications. |
| Vaccine status | TICOVAC is the only U.S.-licensed TBE vaccine and is approved from age 1 year. It uses a three-dose series: dose spacing differs for ages 1-15 and 16 or older, and a booster may be given at least three years later when exposure risk continues. |
History and Public-Health Importance
TBE was recognized in Europe and the Soviet Far East during the twentieth century. Regional vaccines have been used for decades. The FDA licensed TICOVAC in 2021, allowing U.S. travelers and laboratory workers to receive an approved product under ACIP recommendations.
What Causes Tick-borne Encephalitis?
Tick-borne encephalitis virus is a flavivirus transmitted by Ixodes ticks. Rare foodborne infections follow consumption of unpasteurized milk or cheese from infected goats, sheep, or cows.
Infected ticks can transmit virus soon after attachment, so rapid tick removal is important but may not fully prevent TBE. Hiking, camping, forestry, farming, and extended outdoor exposure increase risk. Unlike Lyme disease, ordinary person-to-person transmission does not occur. Unpasteurized dairy has caused localized outbreaks.
Symptoms and Typical Course
Many infections are asymptomatic. Illness may begin with fever, fatigue, headache, muscle aches, and nausea, followed after a symptom-free interval by meningitis or encephalitis with high fever, stiff neck, confusion, weakness, tremor, or seizures.
Some infections have a biphasic pattern: a nonspecific feverish phase, several symptom-free days, then central nervous system disease. Meningitis causes headache and neck stiffness; encephalitis adds confusion, seizures, tremor, or weakness. The Far Eastern subtype is generally more severe than the European subtype.
Complications and Who Is at Higher Risk
Encephalitis can cause paralysis, persistent neurologic disability, cognitive problems, or death. Risk of severe disease rises with age and varies by viral subtype.
Persistent headache, fatigue, memory or concentration problems, balance difficulty, tremor, paralysis, and reduced quality of life can follow. Severe brainstem involvement can compromise breathing or swallowing. Older adults are more likely to have serious outcomes.
How It Is Diagnosed
Travel and outdoor-exposure history is essential. Serum or cerebrospinal-fluid antibody testing confirms infection, often with public-health or reference-laboratory support. PCR is usually less helpful once neurologic symptoms appear. Clinicians must distinguish TBE from bacterial meningitis, West Nile, Japanese encephalitis, herpes encephalitis, and other tickborne infections.
Treatment and Recovery
No specific antiviral is available. Treatment is supportive and may include hospitalization, seizure control, respiratory support, rehabilitation, and management of brain swelling or other complications.
Hospital care supports breathing, circulation, hydration, and neurologic function. Seizures and brain swelling are treated when present. Rehabilitation may involve physical, occupational, speech, and cognitive therapy. Antibiotics do not treat TBE virus but may be started initially until bacterial causes are excluded.
Vaccine Information
TICOVAC is the only U.S.-licensed TBE vaccine and is approved from age 1 year. It uses a three-dose series: dose spacing differs for ages 1-15 and 16 or older, and a booster may be given at least three years later when exposure risk continues.
TICOVAC uses an inactivated European-subtype virus. Ages 1-15 receive dose two 1-3 months after dose one; people 16 or older receive dose two 14 days to 3 months later. Dose three is 5-12 months after dose two for all ages. A booster at least three years later may be used for ongoing risk. Vaccination does not protect against Lyme disease or other tickborne infections.
Prevention
Use TICOVAC when itinerary and exposure warrant it, wear permethrin-treated clothing, apply EPA-registered repellent, stay on trails, perform tick checks, shower after outdoor activity, remove ticks promptly, and avoid unpasteurized dairy in risk areas.
When to Seek Medical Care
Seek urgent care for fever with severe headache, stiff neck, confusion, seizures, weakness, or paralysis during or after travel to a TBE area. Provide exact destinations, dates, and outdoor activities.
Frequently Asked Questions
Is TBE found in the United States?
It is not endemic in the United States; most U.S. concern involves travel or laboratory exposure.
Does TICOVAC protect against Lyme disease?
No. The diseases have different causes, so tick precautions remain necessary.
Who should consider vaccination?
People moving to endemic areas, those with extensive tick exposure, and selected travelers based on itinerary and season.
How many TICOVAC doses are needed?
Three primary doses, with timing based on age, plus a possible booster for continued risk.
Key Takeaway
TBE is a potentially disabling travel infection. Match TICOVAC to the itinerary and combine vaccination with disciplined tick and food precautions.
Medical, treatment, and vaccine information was reviewed against official U.S. public-health guidance available through September 2026.